GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tascom Co Ltd (XKRX:336040) » Definitions » YoY EBITDA Growth

Tascom Co (XKRX:336040) YoY EBITDA Growth : 0.00% (As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is Tascom Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Tascom Co's YoY EBITDA Growth for the quarter that ended in . 20 was 0.00%.

Tascom Co's EBITDA per Share for the six months ended in . 20 was ₩0.00.

Tascom Co YoY EBITDA Growth Historical Data

The historical data trend for Tascom Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tascom Co YoY EBITDA Growth Chart

Tascom Co Annual Data
Trend
YoY EBITDA Growth

Tascom Co Semi-Annual Data
YoY EBITDA Growth

Tascom Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Tascom Co's YoY EBITDA Growth for the fiscal year that ended in . 20 is calculated as:

YoY EBITDA Growth (A: . 20 )
=(EBITDA per Share (A: . 20 )-EBITDA per Share (A: . 20 ))/ | EBITDA per Share (A: . 20 ) |
=(-)/ | |
=N/A %

Tascom Co's YoY EBITDA Growth for the quarter that ended in . 20 is calculated as:

YoY EBITDA Growth (Q: . 20 )
=(EBITDA per Share (Q: . 20 )-EBITDA per Share (Q: . 20 )) / | EBITDA per Share (Q: . 20 ) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tascom Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Tascom Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Tascom Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tascom Co Ltd (XKRX:336040) » Definitions » YoY EBITDA Growth
Comparable Companies
XKRX:114450 XKRX:018620 XKRX:053950 XKRX:018680 XKRX:080720 XKRX:354390 XKRX:233250 XKRX:446600 XKRX:900120 XKRX:191420 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
43 BanPo-daero 28-gil, 5th Floor, i-SENS Building, SeoCho-gu, Seoul, KOR
Website
http://www.yidobio.com
Tascom Co Ltd, formerly YIDOBIO Inc is a diabetes specialty company in Korea. The company develop cell therapy for the treatment of diabetes. It also manufactures and distributes diabetic supplies. The company's products include Blood glucose measurement system-acuraview, BD Ultra Fine PRO Pen Needle, Syringes-BD Ultrafine Syringes, Ido Sharp Container, and Ido safety lancet.

Tascom Co Headlines

No Headlines